Tuesday, December 5, 2017

Very Important!!! Be A Medical Hero!!!

Research sites are opening for the Givosarin drug to prevent attacks in Miami, Wake Forest , NC, Galveston, TX, New York, Philadelphia, San Francisco, Ann Arbor, MI, Salt Lake City, Little Rock, Boston,
The new drug, Givosarin, is being researched to prevent acute porphyria attacks and hopefully the chronic pain associated with acute porphyria..aip, hcp, vp, Adp.
So far, the results of a trial have been very impressive. We cannot have new treatment without You as a volunteer. Participation and travel is free . 

Call the APF toll free 866-APF-3635.

No comments:

Post a Comment

What is δ-Aminolevulinic Acid Dehydratase Porphyria (ADP)?

What is δ-Aminolevulinic Acid Dehydratase Porphyria (ADP)? ADP is more severe than the other acute porphyrias and can present in childhoo...